The combination of Tesamorelin and Ipamorelin. peptides in research settings offers a synergistic approach to modulating growth hormone dynamics in test subjects. Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, selectively stimulates the secretion of endogenous growth hormone by acting on the pituitary gland, enhancing somatotropic axis function. On the other hand, Ipamorelin belongs to the class of growth hormone secretagogues (GHS) or (GHRP), a selective ghrelin receptor agonist, further potentiates this process by binding to the ghrelin receptor, stimulating the release of growth hormone while minimizing undesired effects such as increased cortisol or prolactin secretion. Â The combined effect of Tesamorelin and Ipamorelin offers valuable insights into growth hormone regulation and its physiological effects in a controlled laboratory environment.
Summary of Characteristics
| Characteristic | Tesamorelin | Ipamorelin |
|---|---|---|
| Chemical Sequence | Ac-D2-Ser-His-Phe-Ser-Ser-Ser-Trp-Ala-Phe-Gly | Aib-His-D-Trp-Phe-Thr-Ala-Phe-Met |
| Molecular Formula | C181H220N44O42 | C38H49N9O5 |
| Molecular Weight | 3357.1 g/mol | 711.9 g/mol |
| Other Known Titles | TH9507 | NNC 26-0161 |
